Search Results 81-90 of 44900 for Two-phase

1. Phase 1/2 Dose Escalation And Efficacy Study Of Anti-CD38 Monoclonal Antibody In Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

   - To assess the pharmacodynamics (PD), immune response, and preliminary disease response. Phase 2 (stage 1): to evaluate the following objectives for Isatuximab ...

2. Clinical trials - Oncology (Medical)

   This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

3. Phase 1/2 Dose Escalation Study In Patients With Relapsed Or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

   Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 90% of the patients with Waldenström's macroglobulinemia.

4. A First-in-human Study Of 3HP-2827 In Patients With Unresectable Or Metastatic Solid Tumors With FGFR2 Alterations - Mayo Clinic

   Patients will be enrolled in two stages: dose escalation stage (Stage I) and expansion stage (Stage II). Participation eligibility. Participant eligibility ...

5. A Study Of Patients With Relapsed Or Refractory Acute Myeloid Leukemia (AML) With MCL-1 Dependence ≥ 40% - Mayo Clinic

   The purpose of this two-stage Phase 2 study is to assess the clinical response (Complete Remission) to FLAM compared to AM treatment in refractory or ...

6. Biliopancreatic diversion with duodenal switch (BPD/DS) - Mayo Clinic

   A biliopancreatic diversion with duodenal switch (BPD/DS) is a less common weight-loss procedure that is done in two major steps. The first step is sleeve ...

7. Clinical trials - Oncology (Medical)

   ... phase II dose (RP2D of APG2575 in combination with ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

8. Clinical trials - Oncology (Medical)

   ... phase II dose (RP2D of APG2575 in combination with ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

9. Clinical trials - Oncology (Medical)

   This phase III trial studies whether inotuzumab ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

10. A Phase 2 Study Of CPI-0610 With And Without Ruxolitinib In Patients With Myelofibrosis - Mayo Clinic

    About this study. The purpose of trhis study is to evaluate CPI-0610 in patients who have both received JAK inhibitors, such as ruxolitinib (Arms 1 and 2), ...